Track topics on Twitter Track topics that are important to you
The active pharmaceutical ingredients unit was bought by Perrigo as part of the $818 million acquisition of Agis in 2005.
Original Article: SK Capital buys Perrigo's Israel unit Chemagis for $110mNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...